Ledger.Open graph →
SEC Form D · Amendment · filed December 1, 2025

Tasca Therapeutics Corp

Offering
$70.2M
Sold
$48.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Praveen Tipirneni · Cambridge, MADirectorDrew King · Cambridge, MAExecMilenko Cicmil · Cambridge, MAExec · DirectorXu Wu · Cambridge, MADirectorMichael Aberman · New York, NYDirectorDavid Fallace · Cambridge, MADirectorSeth Lieblich · Cambridge, MADirectorPraveen Tipirneni · Cambridge, MADirectorDavid Fallace · Cambridge, MADirectorSeth Lieblich · Cambridge, MADirectorMichael Aberman · New York, NYDirectorDrew King · Cambridge, MAExecMilenko Cicmil · Cambridge, MAExec · DirectorXu Wu · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗